BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 21875910)

  • 21. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.
    Widder JD; Guzik TJ; Mueller CF; Clempus RE; Schmidt HH; Dikalov SI; Griendling KK; Jones DP; Harrison DG
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):762-8. PubMed ID: 17272743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.
    Sarr M; Chataigneau M; Martins S; Schott C; El Bedoui J; Oak MH; Muller B; Chataigneau T; Schini-Kerth VB
    Cardiovasc Res; 2006 Sep; 71(4):794-802. PubMed ID: 16822492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of lysozyme M-positive cells prevents aircraft noise-induced vascular damage without improving cerebral side effects.
    Frenis K; Helmstädter J; Ruan Y; Schramm E; Kalinovic S; Kröller-Schön S; Bayo Jimenez MT; Hahad O; Oelze M; Jiang S; Wenzel P; Sommer CJ; Frauenknecht KBM; Waisman A; Gericke A; Daiber A; Münzel T; Steven S
    Basic Res Cardiol; 2021 Apr; 116(1):31. PubMed ID: 33929610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Vascular Dysfunction and Inflammation Induced by Angiotensin II in Mice.
    Lagrange J; Kossmann S; Wenzel P
    Methods Mol Biol; 2017; 1559():439-453. PubMed ID: 28063062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction.
    Jansen T; Kröller-Schön S; Schönfelder T; Foretz M; Viollet B; Daiber A; Oelze M; Brandt M; Steven S; Kvandová M; Kalinovic S; Lagrange J; Keaney JF; Münzel T; Wenzel P; Schulz E
    Cardiovasc Res; 2018 Dec; 114(14):1883-1893. PubMed ID: 29982418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice.
    Nishida M; Ishikawa T; Saiki S; Sunggip C; Aritomi S; Harada E; Kuwahara K; Hirano K; Mori Y; Kim-Mitsuyama S
    Biochem Biophys Res Commun; 2013 May; 434(2):210-6. PubMed ID: 23537646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
    Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
    Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats.
    Nyby MD; Abedi K; Smutko V; Eslami P; Tuck ML
    Hypertens Res; 2007 May; 30(5):451-7. PubMed ID: 17587757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice.
    Jung O; Marklund SL; Geiger H; Pedrazzini T; Busse R; Brandes RP
    Circ Res; 2003 Oct; 93(7):622-9. PubMed ID: 12933702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans.
    Wenzel P; Rossmann H; Müller C; Kossmann S; Oelze M; Schulz A; Arnold N; Simsek C; Lagrange J; Klemz R; Schönfelder T; Brandt M; Karbach SH; Knorr M; Finger S; Neukirch C; Häuser F; Beutel ME; Kröller-Schön S; Schulz E; Schnabel RB; Lackner K; Wild PS; Zeller T; Daiber A; Blankenberg S; Münzel T
    Eur Heart J; 2015 Dec; 36(48):3437-46. PubMed ID: 26516175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.
    Landmesser U; Cai H; Dikalov S; McCann L; Hwang J; Jo H; Holland SM; Harrison DG
    Hypertension; 2002 Oct; 40(4):511-5. PubMed ID: 12364355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2.
    Zhang Y; Griendling KK; Dikalova A; Owens GK; Taylor WR
    Hypertension; 2005 Oct; 46(4):732-7. PubMed ID: 16172434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox).
    Rey FE; Li XC; Carretero OA; Garvin JL; Pagano PJ
    Circulation; 2002 Nov; 106(19):2497-502. PubMed ID: 12417549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertension.
    Syrbe U; Moebes A; Scholze J; Swidsinski A; Dörffel Y
    Hypertens Res; 2007 Jun; 30(6):521-8. PubMed ID: 17664855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.
    Barhoumi T; Kasal DA; Li MW; Shbat L; Laurant P; Neves MF; Paradis P; Schiffrin EL
    Hypertension; 2011 Mar; 57(3):469-76. PubMed ID: 21263125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMEM16A Contributes to Endothelial Dysfunction by Facilitating Nox2 NADPH Oxidase-Derived Reactive Oxygen Species Generation in Hypertension.
    Ma MM; Gao M; Guo KM; Wang M; Li XY; Zeng XL; Sun L; Lv XF; Du YH; Wang GL; Zhou JG; Guan YY
    Hypertension; 2017 May; 69(5):892-901. PubMed ID: 28320851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A CCR2/CCR5 antagonist attenuates an increase in angiotensin II-induced CD11b+ monocytes from atherogenic ApoE-/- mice.
    Major TC; Olszewski B; Rosebury-Smith WS
    Cardiovasc Drugs Ther; 2009 Apr; 23(2):113-20. PubMed ID: 19052854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial α1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction.
    Kröller-Schön S; Jansen T; Tran TLP; Kvandová M; Kalinovic S; Oelze M; Keaney JF; Foretz M; Viollet B; Daiber A; Kossmann S; Lagrange J; Frenis K; Wenzel P; Münzel T; Schulz E
    Basic Res Cardiol; 2019 Jan; 114(2):8. PubMed ID: 30643968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced macrophage-dependent inflammation improves endothelin-1-induced vascular injury.
    Javeshghani D; Barhoumi T; Idris-Khodja N; Paradis P; Schiffrin EL
    Hypertension; 2013 Jul; 62(1):112-7. PubMed ID: 23670300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure.
    Yildirim A; Russell J; Yan LS; Senchenkova EY; Granger DN
    Hypertension; 2012 Dec; 60(6):1503-9. PubMed ID: 23090770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.